Binding Site’s novel laboratory blood assays for intact immunoglobulins, Hevylite®, have recently become the only automated immunoassay cleared by the FDA for monitoring IgA and IgG Multiple Myeloma patients.
Binding Site is delighted to announce the approval of their patent application for their Hevylite® assays, novel laboratory blood tests that enable measurement of intact immunoglobulin heavy/light chains, e.g. IgGκ or IgGλ, in serum.
New white paper compares polyclonal and monoclonal antibody-based assays.
These videos show the increasing utility of Freelite® and Hevylite® in a clinical setting.
Binding Site thrilled to have hosted Science Capital Event in September 2013
The Binding Site is happy to announce Cure Leukaemia as it's chose charity for 2013/14
The polyclonal Freelite® assay is now included in the Chinese Multiple Myeloma Diagnosis and Treatment Guidelines.
Binding Site proud to have supported Edward's Trust
Binding Site takes centre stage in thrilling new BBC drama.